Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Mesenchymal stem cells regulate airway contractile tissue remodeling in murine experimental asthma

  • Mariñas-Pardo, Luis
  • Mirones, Isabel
  • Amor-Carro, Oscar|||0009-0009-0696-5739
  • Fraga-Iriso, Rebeca
  • Lema-Costa, Beatriz
  • Cubillo, Isabel María
  • Rodríguez Milla, Miguel Ángel
  • García-Castro, Javier
  • Ramos-Barbón, David|||0000-0002-9615-6557
Background Mesenchymal stem cells may offer therapeutic potential for asthma due to their immunomodulatory properties and host tolerability, yet prior evidence suggests that bloodborne progenitor cells may participate in airway remodeling. Here, we tested whether mesenchymal stem cells administered as anti-inflammatory therapy may favor airway remodeling and therefore be detrimental. Methods Adipose tissue-derived mesenchymal stem cells were retrovirally transduced to express green fluorescent protein and intravenously injected into mice with established experimental asthma induced by repeat intranasal house dust mite extract. Controls were house dust mite-instilled animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving mesenchymal stem cells. Data on lung function, airway inflammation, and remodeling were collected at 72 h after injection or after 2 weeks of additional intranasal challenge. Results The mesenchymal stem cells homed to the lungs and rapidly downregulated airway inflammation in association with raised T-helper-1 lung cytokines, but such effect declined under sustained allergen challenge despite a persistent presence of mesenchymal stem cells. Conversely, airway hyperresponsiveness and contractile tissue underwent a late reduction regardless of continuous pathogenic stimuli and inflammatory rebound. Tracking of green fluorescent protein did not show mesenchymal stem cell integration or differentiation in airway wall tissues. Conclusions Therapeutic mesenchymal stem cell infusion in murine experimental asthma is free of unwanted pro-remodeling effects and ameliorates airway hyper-responsiveness and contractile tissue remodeling. These outcomes support furthering the development of mesenchymal stem cell-based asthma therapies, although caution and solid preclinical data building are warranted. © 2014 The Authors. Allergy published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A Rewired NADPH-Dependent Redox Shuttle for Testing Peroxisomal Compartmentalization of Synthetic Metabolic Pathways in Komagataella phaffii

  • Fina Romero, Albert|||0000-0001-7949-0484
  • Àvila-Cabré, Sílvia|||0000-0001-6179-4877
  • Vázquez Pereira, Enrique|||0000-0002-0561-9000
  • Albiol i Sala, Joan|||0000-0001-5626-429X
  • Ferrer, Pau|||0000-0002-5287-4127
The introduction of heterologous pathways into microbial cell compartments offers several potential advantages, including increasing enzyme concentrations and reducing competition with native pathways, making this approach attractive for producing complex metabolites like fatty acids and fatty alcohols. However, measuring subcellular concentrations of these metabolites remains technically challenging. Here, we explored 3-hydroxypropionic acid (3-HP), readily quantifiable and sharing the same precursors-acetyl-CoA, NADPH, and ATP-with the above-mentioned products, as a reporter metabolite for peroxisomal engineering in the yeast Komagataella phaffii. To this end, the malonyl-CoA reductase pathway for 3-HP production was targeted into the peroxisome of K. phaffii using the PTS1-tagging system, and further tested with different carbon sources. Thereafter, we used compartmentalized 3-HP production as a reporter system to showcase the impact of different strategies aimed at enhancing the peroxisomal NADPH pool. Co-overexpression of genes encoding a NADPH-dependent redox shuttle from Saccharomyces cerevisiae (IDP2 / IDP3) significantly increased 3-HP yields across all substrates, whereas peroxisomal targeting of the S. cerevisiae NADH kinase Pos5 failed to improve 3-HP production. This study highlights the potential of using peroxisomal 3-HP production as a biosensor for evaluating peroxisomal acetyl-CoA and NAPDH availability by simply quantifying 3-HP, demonstrating its potential for peroxisome-based metabolic engineering in yeast.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Feminisme marxista censurat als anys setanta, Marxist Feminism censored in the 1970s, Feminismo marxista censurado en los años setenta

  • Godayol, Pilar|||0000-0003-2513-5334
A partir del segle XIX el socialisme va promoure un nou corrent de pensament dins del feminisme. Flora Tristán (1803-1844), Clara Zetkin (1857-1933), Alexandra Kollontai (1872-1945), Juliet Mitchell (1940) o Sheila Rowbotham (1943) són algunes de les mares simbòliques de la literatura feminista socialista i marxista que van arribar a Catalunya durant la segona meitat dels anys setanta, entre 1975 i 1978. En aquest article presentem breument les teories d'aquestes cinc autores -que, en general, busquen estratègies per lluitar alhora contra el patriarcat i el capitalisme- i resseguim la recepció i la censura postfranquista dels seus assaigs en ser traduïts al castellà -i un al català- per tres editorials barcelonines: Anagrama, Edicions 62 i Fontamara. També revisem els set expedients (actualment custodiats a l'Archivo General de la Administración, AGA), que el Ministerio de Información y Turismo (MIT) va obrir a aquestes editorials., From the 19th century onwards, socialism promoted a new current of thought within feminism. Flora Tristán (1803-1844), Clara Zetkin (1857-1933), Alexandra Kollontai (1872-1945), Juliet Mitchell (1940) and Sheila Rowbotham (1943) are some of the symbolic mothers of socialist and Marxist feminist literature that arrived in Catalonia during the second half of the 1970s, between 1975 and 1978. In this article, we briefly present the theories of these five authors- who, in general, seek strategies to fight against patriarchy and capitalism at the same time-and we trace the reception and post-Franco censorship that their essays experienced when they were translated into Spanish-and one into Catalan-by three Barcelona publishing houses: Anagrama, Edicions 62 and Fontamara. We also review the seven files (currently kept in the Archivo General de la Administración, AGA), which the Ministry of Information and Tourism (MIT) opened to these publishers., A partir del siglo XIX el socialismo promovió una nueva corriente de pensamiento dentro del feminismo. Flora Tristán (1803-1844), Clara Zetkin (1857-1933), Alexandra Kollontai (1872-1945), Juliet Mitchell (1940) o Sheila Rowbotham (1943) son algunas de las madres simbólicas de la literatura feminista socialista y marxista que llegó a Cataluña durante la segunda mitad de los años setenta. En este artículo presentamos brevemente las teorías de estas cinco autoras -que, por lo general, buscan estrategias para luchar a la vez contra el patriarcado y el capitalismo- y reseguimos la recepción y la censura posfranquista que experimentaron sus ensayos al ser traducidos al castellano - y uno al catalán- por tres editoriales barcelonesas: Anagrama, Edicions 62 y Fontamara. A tal fin, también revisamos los siete expedientes abiertos a estas editoriales, actualmente custodiados en el Archivo General de la Administración (AGA).
Repisalud
Publication Artículo científico (JournalArticle)

The G4 resolvase Dhx36 modulates cardiomyocyte differentiation and ventricular conduction system development

  • Gomez-del Arco, Pablo
  • Isern, Joan
  • Jimenez-Carretero, Daniel
  • Lopez-Maderuelo, Dolores
  • Piñeiro-Sabarís, Rebeca
  • El Abdellaoui-Soussi, Fadoua
  • Torroja, Carlos
  • Vera-Pedrosa, María Linarejos
  • Grima-Terrén, Mercedes
  • Benguria, Alberto
  • Simón-Chica, Ana
  • Queiro-Palou, Antonio
  • Dopazo, Ana
  • Sanchez-Cabo, Fatima
  • Jalife, Jose
  • de la Pompa, Jose Luis
  • Filgueiras-Rama, David
  • Munoz-Canoves, Pura
  • Redondo, Juan Miguel
Extensive genetic studies have elucidated cardiomyocyte differentiation and associated gene networks using single-cell RNA-seq, yet the intricate transcriptional mechanisms governing cardiac conduction system (CCS) development and working cardiomyocyte differentiation remain largely unexplored. Here we show that mice deleted for Dhx36 (encoding the Dhx36 helicase) in the embryonic or neonatal heart develop overt dilated cardiomyopathy, surface ECG alterations related to cardiac impulse propagation, and (in the embryonic heart) a lack of a ventricular conduction system (VCS). Heart snRNA-seq and snATAC-seq reveal the role of Dhx36 in CCS development and in the differentiation of working cardiomyocytes. Dhx36 deficiency directly influences cardiomyocyte gene networks by disrupting the resolution of promoter G-quadruplexes in key cardiac genes, impacting cardiomyocyte differentiation and CCS morphogenesis, and ultimately leading to dilated cardiomyopathy and atrioventricular block. These findings further identify crucial genes and pathways that regulate the development and function of the VCS/Purkinje fiber (PF) network.
IRTA Pubpro. Open Digital Archive
Publication Artículo científico (JournalArticle)

Gestational Caloric Restriction Alters Adipose Tissue Methylome and Offspring’s Metabolic Profile in a Swine Model

  • Mas-Parés, Berta
  • Xargay-Torrent, Sílvia
  • Carreras-Badosa, Gemma
  • Gómez-Vilarrubla, Ariadna
  • Niubó-Pallàs, Maria
  • Tibau , Joan
  • Reixach, Josep
  • Prats-Puig, Anna
  • de Zegher, Francis
  • Ibañez, Lourdes
  • Bassols, Judit
  • López-Bermejo, Abel
Limited nutrient supply to the fetus results in physiologic and metabolic adaptations that have unfavorable consequences in the offspring. In a swine animal model, we aimed to study the effects of gestational caloric restriction and early postnatal metformin administration on offspring’s adipose tissue epigenetics and their association with morphometric and metabolic variables. Sows were either underfed (30% restriction of total food) or kept under standard diet during gestation, and piglets were randomly assigned at birth to receive metformin (n = 16 per group) or vehicle treatment (n = 16 per group) throughout lactation. DNA methylation and gene expression were assessed in the retroperitoneal adipose tissue of piglets at weaning. Results showed that gestational caloric restriction had a negative effect on the metabolic profile of the piglets, increased the expression of inflammatory markers in the adipose tissue, and changed the methylation of several genes related to metabolism. Metformin treatment resulted in positive changes in the adipocyte morphology and regulated the methylation of several genes related to atherosclerosis, insulin, and fatty acids signaling pathways. The methylation and gene expression of the differentially methylated FASN, SLC5A10, COL5A1, and PRKCZ genes in adipose tissue associated with the metabolic profile in the piglets born to underfed sows. In conclusion, our swine model showed that caloric restriction during pregnancy was associated with impaired inflammatory and DNA methylation markers in the offspring’s adipose tissue that could predispose the offspring to later metabolic abnormalities. Early metformin administration could modulate the size of adipocytes and the DNA methylation changes., The study was supported by grants from the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Madrid, Spain (PI20/00399 to J.B. and PI19/00451 and PI22/00366 to A.L.-B.), projects co-funded by FEDER (Fondo Europeo de Desarrollo Regional)., info:eu-repo/semantics/publishedVersion
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms

  • Esparza Baquer, Aitor
  • Labiano Ciriza, Ibone
  • Sharif, Omar
  • Agirre Lizaso, Aloña
  • Oakley, Fiona
  • Rodrigues, Pedro M.
  • Zhuravleva, Ekaterina
  • O'Rourke, Colm J.
  • Hijona Muruamendiaraz, Elizabeth
  • Jiménez Agüero, Raúl
  • Riaño Fernández, Ioana
  • Landa Magdalena, Ana
  • La Casta, Adelaida
  • Zaki, Marco Y. W.
  • Muñoz, Patricia
  • Azkargorta, Mikel
  • Elortza, Felix
  • Vogel, Andrea
  • Schabbauer, Gernot
  • Aspichueta Celaá, Patricia
  • Andersen, Jesper B.
  • Knapp, Sylvia
  • Mann, Derek A.
  • Bujanda Fernández de Pierola, Luis
  • Bañales Asurmendi, Jesús María
  • Perugorria Montiel, María Jesús
[EN] Objective Hepatocellular carcinoma (HCC) is a prevalent and aggressive cancer usually arising on a background of chronic liver injury involving inflammatory and hepatic regenerative processes. The triggering receptor expressed on myeloid cells 2 (TREM-2) is predominantly expressed in hepatic non-parenchymal cells and inhibits Toll-like receptor signalling, protecting the liver from various hepatotoxic injuries, yet its role in liver cancer is poorly defined. Here, we investigated the impact of TREM-2 on liver regeneration and hepatocarcinogenesis. Design TREM-2 expression was analysed in liver tissues of two independent cohorts of patients with HCC and compared with control liver samples. Experimental HCC and liver regeneration models in wild type and Trem-2-/- mice, and in vitro studies with hepatic stellate cells (HSCs) and HCC spheroids were conducted. Results TREM-2 expression was upregulated in human HCC tissue, in mouse models of liver regeneration and HCC. Trem-2-/- mice developed more liver tumours irrespective of size after diethylnitrosamine (DEN) administration, displayed exacerbated liver damage, inflammation, oxidative stress and hepatocyte proliferation. Administering an antioxidant diet blocked DEN-induced hepatocarcinogenesis in both genotypes. Similarly, Trem-2-/- animals developed more and larger tumours in fibrosis-associated HCC models. Trem-2-/- livers showed increased hepatocyte proliferation and inflammation after partial hepatectomy. Conditioned media from human HSCs overexpressing TREM-2 inhibited human HCC spheroid growth in vitro through attenuated Wnt ligand secretion. Conclusion TREM-2 plays a protective role in hepatocarcinogenesis via different pleiotropic effects, suggesting that TREM-2 agonism should be investigated as it might beneficially impact HCC pathogenesis in a multifactorial manner., Spanish Ministry of Economy and Competitiveness and ’Instituto de Salud Carlos III’ grants (MJP (PI14/00399, PI17/00022 and Ramon y Cajal Programme RYC-2015–17755); JMB (PI12/00380, PI15/01132, PI18/01075, Miguel Servet Programme CON14/00129 and CPII19/00008) cofinanced by ’Fondo Europeo de Desarrollo Regional’ (FEDER); CIBERehd: MJP, JMB and LB), Spain; IKERBASQUE, Basque foundation for Science (MJP and JMB), Spain; ’Diputación Foral de Gipuzkoa’ (MJP: DFG18/114, DFG19/081; JMB: DFG15/010, DFG16/004); BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/ BD to JMB); Department of Health of the Basque Country (MJP: 2015111100 and 2019111024; JMB: 2017111010), Euskadi RIS3 (JMB: 2016222001, 2017222014, 2018222029, 2019222054, 2020333010) Department of Industry of the Basque Country (JMB: Elkartek: KK-2020/00008) and AECC Scientific Foundation (JMB). AE-B was funded by the University of the Basque Country (UPV/EHU) (PIF2014/11) and by the short-term training fellowship Andrew K Burroughs (European Association for the Study of the Liver, EASL). IL and AA-L were funded by the Department of Education, Language Policy and Culture of the Basque Government (PRE_2016_1_0152 and PRE_2018_1_0184). OS and SK were funded by the Austrian Science Fund (FWF25801-B22, FWF-P35168 to OS and L-Mac: F 6104-B21 to SK). FO and DAM were funded by a UK Medical Research Council programme Grant MR/R023026/1. DAM was also funded by the CRUK programme grant C18342/A23390, CRUK/AECC/AIRC Accelerator Award A26813 and the MRC MICA programme grant MR/R023026/1. JBA is supported by the Danish Medical Research Council, Danish Cancer Society, Nordisk Foundation, and APM Foundation. CJO’R and PM-G are supported by Marie Sklodowska-Curie Programme and EASL Sheila Sherlock postdoctoral fellowships.
Addi. Archivo Digital para la Docencia y la Investigación
Publication Artículo científico (JournalArticle)

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease

  • Caballero Camino, Francisco Javier
  • Rivilla de la Cruz, Iván
  • Herráez Aguilar, Elisa
  • Briz Sánchez, Oscar
  • Santos Laso, Álvaro
  • Izquierdo Sánchez, Laura
  • Lee-Law, Pui Y.
  • Rodrigues, Pedro M.
  • Muñoz Garrido, Patricia
  • Jin, Sujeong
  • Peixoto, Estanislao
  • Richard, Seth
  • Gradilone, Sergio A.
  • Perugorria Montiel, María Jesús
  • Esteller, Manel
  • Bujanda Fernández de Pierola, Luis
  • Marín, José J. G.
  • Bañales Asurmendi, Jesús María
  • Cossío Mora, Fernando Pedro
Background and Aims Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current surgical and pharmacological approaches are ineffective, and liver transplantation represents the only curative option. Ursodeoxycholic acid (UDCA) and histone deacetylase 6 inhibitors (HDAC6is) have arisen as promising therapeutic strategies, but with partial benefits. Approach and Results Here, we tested an approach based on the design, synthesis, and validation of a family of UDCA synthetic conjugates with selective HDAC6i capacity (UDCA-HDAC6i). Four UDCA-HDAC6i conjugates presented selective HDAC6i activity, UDCA-HDAC6i #1 being the most promising candidate. UDCA orientation within the UDCA-HDAC6i structure was determinant for HDAC6i activity and selectivity. Treatment of polycystic rats with UDCA-HDAC6i #1 reduced their hepatomegaly and cystogenesis, increased UDCA concentration, and inhibited HDAC6 activity in liver. In cystic cholangiocytes UDCA-HDAC6i #1 restored primary cilium length and exhibited potent antiproliferative activity. UDCA-HDAC6i #1 was actively transported into cells through BA and organic cation transporters. Conclusions These UDCA-HDAC6i conjugates open a therapeutic avenue for PLDs., Supported by the Spanish Carlos III Health Institute (ISCIII; J.M. Banales: FIS PI15/01132, PI18/01075 and Miguel Servet Program CON14/00129; M.J. Perugorria: PI14/00399, PI17/00022; J.J.G. Marin: FIS PI16/00598) cofinanced by "Fondo Europeo de Desarrollo Regional" (FEDER); CIBERehd (ISCIII): J.M. Banales, M.J. Perugorria, L. Bujanda, and J.J.G. Marin; Spanish Ministry of Economy and Competitiveness (M. J. Perugorria: Ramon y Cajal Program RYC-2015-17755); IKERBASQUE, Basque foundation for Science (M.J. Perugorria and J.M. Banales), Spain; "Junta de Castilla y Leon" (J.J.G. Marin: SA06P17); " Diputacion Foral Gipuzkoa" (J.M. Banales: DFG15/010, DFG16/004; M.J. Perugorria: DFG18/114, DFG19/081), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J.M. Banales), Department of Health of the Basque Country (J.M. Banales: 2017111010; M.J. Perugorria: 2019111024), and Euskadi RIS3 (J.M. Banales: 2016222001, 2017222014, and 2018222029; 2019222054); La Caixa Scientific Foundation (J.M. Banales: HR17-00601); "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation, to J.M. Banales and J.J.G. Marin); and "Centro Internacional sobre el Envejecimiento", Spain (J.J.G. Marin: OLD-HEPAMARKER, 0348-CIE-6-E). F.J. Caballero-Camino was funded by the Spanish Ministry of Science and Innovation (BES-2014-069148), A. Santos-Laso by the Basque Government (PRE_2018_2_0195), and Pui Y. Lee-Law by the European Association for the Study of the Liver (EASL; Sheila Sherlock Award). The Spanish Ministry of Science and Innovation supported F. P. Cossio: (CTQ2016-80375-P and CTQ2014-51912-REDC) as well as the Basque Government (F.P. Cossio: IT-324-07). I. Rivilla had a postdoctoral contract from the Donostia International Physics Center.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

  • Oliva-Ariza, Guillermo
  • Fuentes-Herrero, Blanca
  • Carbonell, Cristina
  • Lécrevisse, Quentin
  • Pérez-Pons, Alba
  • Torres-Valle, Alba
  • Pozo, Julio
  • Martín-Oterino, José Ángel
  • González-López, Óscar
  • López-Bernús, Amparo
  • Bernal-Ribes, Marta
  • Belhassen-García, Moncef
  • Pérez-Escurza, Oihane
  • Pérez-Andrés, Martin
  • Vázquez-López, Lourdes
  • Hernández-Pérez, Guillermo
  • García Palomo, Francisco Javier
  • Leoz, Pilar
  • Costa-Alba, Pilar
  • Pérez-Losada, Elena
  • Yeguas Bermejo, Ana
  • Santos Sánchez, Miryam
  • García-Blázquez, Marta
  • Morán-Plata, F. Javier
  • Damasceno, Daniela
  • Botafogo, Vitor
  • Muñoz-García, Noemí
  • Fluxá, Rafael
  • Contreras-Sanfeliciano, Teresa
  • Almeida, Julia
  • Marcos, Miguel
  • Orfao, Alberto
Low-count monoclonal B-cell lymphocytosis (MBLlo, <500 clonal B-cells/μL) is a highly prevalent condition in the general population (4% to 16% of otherwise healthy adults), which increases significantly with age.1-7 In most cases, clonal B-cells share phenotypic and cytogenetic features with chronic lymphocytic leukemia (CLL), but only a small fraction (≈1.8%) progresses to high-count MBL (MBLhi; ≥500 and <5000 clonal B-cells/μL)3 in the medium-term.8 However, previous reports showed that MBLlo subjects had an increased risk of severe infections in association with a (predominantly) secondary antibody deficiency,8-10 suggesting that MBLlo might be a risk marker for developing more severe infections., This work was supported by the Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación, Madrid, Spain, and FONDOS FEDER (a way to build Europe) grants CB16/12/00400 (CIBERONC), COV20/00386, and PI17/00399; the Consejería de Educación and the Gerencia Regional de Salud, Consejería de Sanidad from Junta de Castilla y León (Valladolid, Spain) grants SA109P20 and GRS-COVID-33/A/20; the European Regional Development Fund (INTERREG POCTEP Spain-Portugal) grant 0639-IDIAL-NET-3-3; and the CRUK (United Kingdom), Fundación AECC (Spain), and Associazione Italiana per la Ricerca Sul Cancro (Italy) “Early Cancer Research Initiative Network on MBL (ECRINM3)” ACCELERATOR award. G.O.-A. is supported by a grant from the Consejería de Educación, Junta de Castilla y León (Valladolid, Spain); B.F.-H. was supported by grant 0639-IDIAL-NET-3-3., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gestational Caloric Restriction Alters Adipose Tissue Methylome and Offspring’s Metabolic Profile in a Swine Model

  • Mas-Parés, Berta
  • Xargay-Torrent, Sílvia
  • Carreras-Badosa, Gemma
  • Gómez-Vilarrubla, Ariadna
  • Niubó-Pallàs, Maria
  • Tibau , Joan
  • Reixach, Josep
  • Prats-Puig, Anna
  • de Zegher, Francis
  • Ibañez, Lourdes
  • Bassols, Judit
  • López-Bermejo, Abel
Limited nutrient supply to the fetus results in physiologic and metabolic adaptations that have unfavorable consequences in the offspring. In a swine animal model, we aimed to study the effects of gestational caloric restriction and early postnatal metformin administration on offspring’s adipose tissue epigenetics and their association with morphometric and metabolic variables. Sows were either underfed (30% restriction of total food) or kept under standard diet during gestation, and piglets were randomly assigned at birth to receive metformin (n = 16 per group) or vehicle treatment (n = 16 per group) throughout lactation. DNA methylation and gene expression were assessed in the retroperitoneal adipose tissue of piglets at weaning. Results showed that gestational caloric restriction had a negative effect on the metabolic profile of the piglets, increased the expression of inflammatory markers in the adipose tissue, and changed the methylation of several genes related to metabolism. Metformin treatment resulted in positive changes in the adipocyte morphology and regulated the methylation of several genes related to atherosclerosis, insulin, and fatty acids signaling pathways. The methylation and gene expression of the differentially methylated FASN, SLC5A10, COL5A1, and PRKCZ genes in adipose tissue associated with the metabolic profile in the piglets born to underfed sows. In conclusion, our swine model showed that caloric restriction during pregnancy was associated with impaired inflammatory and DNA methylation markers in the offspring’s adipose tissue that could predispose the offspring to later metabolic abnormalities. Early metformin administration could modulate the size of adipocytes and the DNA methylation changes., The study was supported by grants from the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Madrid, Spain (PI20/00399 to J.B. and PI19/00451 and PI22/00366 to A.L.-B.), projects co-funded by FEDER (Fondo Europeo de Desarrollo Regional)., info:eu-repo/semantics/publishedVersion
Docta Complutense
Publication Artículo científico (JournalArticle)

Adhesion G protein-coupled receptor Gpr126/Adgrg6 is essential for placental development

  • Torregrosa Carrión, Rebeca
  • Piñeiro-Sabarís, Rebeca
  • Siguero-Álvarez, Marcos
  • Grego-Bessa, Joaquin
  • Luna-Zurita, Luís
  • Leite Fernandes, Vitor Samuel
  • MacGrogan, Donal
  • de la Pompa, José Luís
Mutations in the G protein–coupled receptor GPR126/ADGRG6 cause human diseases, including defective peripheral nervous system (PNS) myelination. To study GPR126 function, we generated new genetic mice and zebrafish models. Murine Gpr126 is expressed in developing heart endocardium, and global Gpr126 inactivation is embryonically lethal, with mutants having thin-walled ventricles but unaffected heart patterning or maturation. Endocardial-specific Gpr126 deletion does not affect heart development or function, and transgenic endocardial GPR126 expression fails to rescue lethality in Gpr126-null mice. Zebrafish gpr126 mutants display unaffected heart development. Gpr126 is also expressed in placental trophoblast giant cells. Gpr126-null mice with a heterozygous placenta survive but exhibit GPR126-defective PNS phenotype. In contrast, Gpr126-null embryos with homozygous mutant placenta die but are rescued by placental GPR126 expression. Gpr126-deficient placentas display down-regulation of preeclampsia markers Mmp9, Cts7, and Cts8. We propose that the placenta-heart axis accounts for heart abnormalities secondary to placental defects in Gpr126 mutants.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome, a population-based cohort study in Catalonia (Spain)

  • Ribera, A.|||0000-0002-2604-6328
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Marsal, Josep Ramon|||0000-0003-0675-6119
  • Oristrell, Gerard|||0000-0003-3217-987X
  • Faixedas, Maria Teresa
  • Rosas, Alba
  • Tizón-Marcos, Helena|||0000-0001-7942-9413
  • Rojas, Sergio
  • Labata, Carlos|||0000-0002-4505-0787
  • Cardenas, Merida
  • Homs, Silvia
  • Tomas-Querol, Carlos
  • García-Picart, Juan
  • Gómez-Hospital, Joan Antoni|||0000-0002-3249-3095
  • Pijoan, Jose Ignacio
  • Masotti, Monica
  • Mauri, Josepa
  • García Dorado, David
Objectives Guidelines recommending 12-month dual antiplatelet therapy (DAPT) in patients with ST-elevation acute coronary syndrome (STEACS) undergoing percutaneous coronary intervention (PCI) were published in year 2012. We aimed to describe the influence of guideline implementation on the trend in 12-month persistence with DAPT between 2010 and 2015 and to evaluate its relationship with DAPT duration regimens recommended at discharge from PCI hospitals. Design Observational study based on region-wide registry data linked to pharmacy billing data for DAPT follow-up. Setting All PCI hospitals (10) belonging to the acute myocardial infarction (AMI) code network in Catalonia (Spain). Participants 10 711 STEACS patients undergoing PCI between 2010 and 2015 were followed up. Primary and secondary outcome measures Primary outcome was 12-month persistence with DAPT. Calendar year quarter, publication of guidelines, DAPT duration regimen recommended in the hospital discharge report, baseline patient characteristics and significant interactions were included in mixed-effects logistic regression based interrupted time-series models. Results The proportion of patients on-DAPT at 12 months increased from 58% (56-60) in 2010 to 73% (71-75) in 2015. The rate of 12-month persistence with DAPT significantly increased after the publication of clinical guidelines with a time lag of 1 year (OR=1.20; 95% CI 1.11 to 1.30). A higher risk profile, more extensive and complex coronary disease, use of drug-eluting stents (OR=1.90; 95% CI 1.50 to 2.40) and a 12-month DAPT regimen recommendation at discharge from the PCI hospital (OR=5.76; 95% CI 3.26 to 10.2) were associated with 12-month persistence. Conclusion Persistence with 12-month DAPT has increased since publication of clinical guidelines. Even though most patients were discharged on DAPT, only 73% with potential indication were on-DAPT 12 months after PCI. A guideline-based recommendation at PCI hospital discharge was highly associated with full persistence with DAPT. Establishing evidence-based, common prescribing criteria across hospitals in the AMI-network would favour adherence and reduce variability.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease

  • Caballero-Camino, F. J.
  • Rivilla, I.|||0000-0003-1984-7183
  • Herraez, Elisa
  • Briz, O.
  • Santos-Laso, A.|||0000-0001-9810-4913
  • Izquierdo-Sanchez, Laura
  • Lee-Law, P. Y.
  • Rodrigues, P. M.|||0000-0001-6193-7436
  • Munoz-Garrido, P.
  • Jin, S.
  • Peixoto, E.
  • Richard, S.
  • Gradilone, S. A.
  • Perugorria, M. J.
  • Esteller, M.|||0000-0003-4490-6093
  • Bujanda, Luis|||0000-0002-4353-9968
  • Marin, J. J. G.
  • Banales, Jesus|||0000-0002-5224-2373
  • Cossío, Fernando P.|||0000-0002-4526-2122
Background and Aims: Polycystic liver diseases (PLDs) are genetic disorders characterized by progressive development of symptomatic biliary cysts. Current surgical and pharmacological approaches are ineffective, and liver transplantation represents the only curative option. Ursodeoxycholic acid (UDCA) and histone deacetylase 6 inhibitors (HDAC6is) have arisen as promising therapeutic strategies, but with partial benefits. Approach and Results: Here, we tested an approach based on the design, synthesis, and validation of a family of UDCA synthetic conjugates with selective HDAC6i capacity (UDCA-HDAC6i). Four UDCA-HDAC6i conjugates presented selective HDAC6i activity, UDCA-HDAC6i #1 being the most promising candidate. UDCA orientation within the UDCA-HDAC6i structure was determinant for HDAC6i activity and selectivity. Treatment of polycystic rats with UDCA-HDAC6i #1 reduced their hepatomegaly and cystogenesis, increased UDCA concentration, and inhibited HDAC6 activity in liver. In cystic cholangiocytes UDCA-HDAC6i #1 restored primary cilium length and exhibited potent antiproliferative activity. UDCA-HDAC6i #1 was actively transported into cells through BA and organic cation transporters. Conclusions: These UDCA-HDAC6i conjugates open a therapeutic avenue for PLDs.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Airway hyperresponsiveness, inflammation, and pulmonary emphysema in rodent models designed to mimic exposure to fuel oil-derived volatile organic compounds encountered during an experimental oil spill

  • Amor-Carro, Oscar|||0009-0009-0696-5739
  • White, K.M.
  • Fraga-Iriso, Rebeca
  • Mariñas-Pardo, L.A.
  • Núñez-Naveira, L.
  • Lema-Costa, B.
  • Villarnovo, M.
  • Verea-Hernando, H.
  • Ramos-Barbón, David|||0000-0002-9615-6557
Fuel oil-derived volatile organic compounds (VOCs) inhalation is associated with accidental marine spills. After the Prestige petroleum tanker sank off northern Spain in 2002 and the Deepwater Horizon oil rig catastrophe in 2009, subjects involved in environmental decontamination showed signs of ongoing or residual lung disease up to 5 y after the exposure. We aimed at investigating mechanisms driving persistent respiratory disease by developing an animal model of inhalational exposure to fuel oil-derived VOCs. Female Wistar and Brown Norway (BN) rats and C57BL mice were exposed to VOCs produced from fuel oil mimicking the Prestige spill. Exposed animals inhaled the VOCs 2 h daily, 5 d per week, for 3 wk. Airway responsiveness to methacholine (MCh) was assessed, and bron-choalveolar lavage (BAL) and lung tissues were analyzed after the exposure and following a 2-wk washout. Consistent with data from human studies, both strains of rats that inhaled fuel oil-derived VOCs developed airway hyperresponsiveness that persisted after the washout period, in the absence of detectable inflammation in any lung compartment. Histopathology and quantitative morphology revealed the development of peripherally distributed pulmonary emphysema, which persisted after the washout period, associated with increased alveolar septal cell apoptosis, microvascular endothelial damage of the lung parenchyma, and inhibited expression of vascular endothelial growth factor (VEGF). In this rat model, fuel oil VOCs inhalation elicited alveolar septal cell apoptosis, likely due to DNA damage. In turn, the development of a peculiar pulmonary emphysema pattern altered lung mechanics and caused persistent noninflammatory airway hyperresponsiveness. Such findings suggest to us that humans might also respond to VOCs through physiopathological pathways different from those chiefly involved in typical cigarette smoke-driven emphysema in chronic obstructive pulmonary disease (COPD). If so, this study could form the basis for a novel disease mechanism for lasting respiratory disease following inhalational exposure to catastrophic fuel oil spills.